Journal of Leukemia
Open Access

ISSN: 2329-6917

+44 1300 500008

Journal of Leukemia : Citations & Metrics Report

Articles published in Journal of Leukemia have been cited by esteemed scholars and scientists all around the world. Journal of Leukemia has got h-index 11, which means every article in Journal of Leukemia has got 11 average citations.

Following are the list of articles that have cited the articles published in Journal of Leukemia.

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Total published articles	60	56	62	62	23	11	8	22	23	48	50	29
Research, Review articles and Editorials	38	44	28	40	2	7	7	14	10	24	27	18
Research communications, Review communications, Editorial communications, Case reports and Commentary	12	12	34	22	21	4	1	8	13	24	23	11
Conference proceedings	0	0	0	0	0	0	0	28	0	0	0	0
Citations received as per Google Scholar, other indexing platforms and portals	0	0	0	54	59	64	98	0	74	0	0	0

Journal total citations count	618
Journal impact factor	2.11
Journal 5 years impact factor	3.71
Journal cite score	3.91
Journal h-index	11
Journal h-index since 2019	8

Important citations (462)

Diabetes, but not pre-diabetes, is associated with shorter time to second-line therapy and worse outcomes in patients with multiple myeloma View at Publisher View at Google Scholar View at Indexing
Ríos-tamayo r, pérez mj, rodríguez ds, chang-chan yl. epidemiology of multiple myeloma. inmultiple myeloma 2018 nov 5. intechopen. View at Publisher View at Google Scholar View at Indexing
Shukla p. umbilical cord preservation-a review. biochem mol biol lett. 2017;3(1):109. View at Publisher View at Google Scholar View at Indexing
Levy i, vadasz z, polliack a, tadmor t. the frequency and prognostic value of neutrophilia in chronic lymphocytic leukemia. anticancer research. 2018 aug 1;38(8):4731-4. View at Publisher View at Google Scholar View at Indexing
raja ramesh gv. cancer metastasis and its suppressor genes. biochem mol biol lett. 2017;3(2):116. View at Publisher View at Google Scholar
alwash mm. evaluation of cd69 as a prognostic factor and its relation with other prognosticatos in a sample of iraqi patients with chronic lymphocytic leukemia. mustansiriya medical journal. 2018 jun 29;14(2):6-. View at Publisher View at Google Scholar
Kirtava t, vatsadze t, azrmaiparashili e, ghirdaladze d. the prognostic significance of combaind expression of zap-70 and cd38 in chronic lymphocytic leukemia. georgian medical news. 2017 jun(267):12-6. View at Publisher View at Google Scholar View at Indexing
Climans sa, cecchini mj, hsia cc, bondy lc, shkrum mj, roth ke, fraser ja. chronic myelomonocytic leukemia mimicking invasive fungal rhinosinusitis. canadian journal of neurological sciences. 2018 sep;45(5):596-8. View at Publisher View at Google Scholar View at Indexing
Umbilical cord preservation- a review View at Publisher View at Google Scholar View at Indexing
Clinical case of transitory anomalomy myelopoesis in a newborn View at Publisher View at Google Scholar View at Indexing
Clinical observation of transient leukemia in a child with down syndrome View at Publisher View at Google Scholar View at Indexing
miachon aa, de martino lee ml, guerra-junior g, spinola-castro am. are survivors of childhood acute lymphoblastic leukemia at increased risk for low bone mass?. journal of leukemia. 2014 aug 26. View at Publisher View at Google Scholar
mcgill cm, brown tj, fisher ln, gustafson sj, dunlap kl, beck aj, toran pt, claxton df, barth bm. combinatorial efficacy of quercitin and nanoliposomal ceramide for acute myeloid leukemia. international journal of biopharmaceutical sciences. 2018;1(1). View at Publisher View at Google Scholar
Ð‘Ð¸Ð³Ð¸Ð»ÑŒÐ´ÐµÐµÐ² ÐÐ•. Ð£Ð¡Ð¢Ð ÐžÐ™Ð¡Ð¢Ð’Ðž Ð˜ Ð Ð•Ð“Ð£Ð›Ð¯Ð¦Ð˜Ð¯ ÐžÐ¢Ð”Ð•Ð›Ð Ð¡Ð¢Ð’ÐžÐ›ÐžÐ’Ð«Ð¥ ÐœÐ•Ð—Ð•ÐÐ¥Ð˜ÐœÐÐ«Ð¥ ÐšÐ›Ð•Ð¢ÐžÐš. ÐœÐ¾ÑÐºÐ²Ð°. 2017. View at Publisher View at Google Scholar
bansal p. research and reviews: journal of microbiology and biotechnology. View at Publisher View at Google Scholar
kirova ym, horn s, chen j. évolution des techniques d'irradiation pour la prise en charge de la maladie de hodgkin: histoire et avenir. cancer/radiotherapie. 2017 aug 1;21(5):400-3. View at Publisher View at Google Scholar
kirova ym, chen j. évolution de techniques d’irradiation dans le cadre de la maladie de hodgkin: il est temps de proposer des techniques modernes à tous nos patients. innovations & thérapeutiques en oncologie. 2017 jan 1;3(1):39-40. View at Publisher View at Google Scholar
starke a, bowden j, lynn r, hall k, hudson k, rato a, aldridge e, robb d, steele p, brady j, mikhaeel ng. comparison of butterfly volumetric modulated arc therapy to full arc with or without deep inspiration breath hold for the treatment of mediastinal lymphoma. radiotherapy and oncology. 2018 dec 1;129(3):449-55. View at Publisher View at Google Scholar
meyer e, goudjil f, tamburini j, dendale r, kirova y. proton beam therapy for the management of mediastinal hodgkin lymphoma in a young female patient. cancer radiotherapie: journal de la societe francaise de radiotherapie oncologique. 2018 may;22(3):296. View at Publisher View at Google Scholar
horn s, fournier-bidoz n, pernin v, peurien d, vaillant m, dendale r, fourquet a, kirova ym. comparison of passive-beam proton therapy, helical tomotherapy and 3d conformal radiation therapy in hodgkin's lymphoma female patients receiving involved-field or involved site radiation therapy. cancer/radiothérapie. 2016 apr 1;20(2):98-103. View at Publisher View at Google Scholar
Prev 1 2 ... 8 9 10 11 12 13 14 15 16 17 18 ... 23 24 Next »

Top